Despite the failure of an eczema trial in December, Q32 Bio is sticking with bempikibart. But a phase 2-stage complement inhibitor and a number of the biotech’s “valued colleagues” won’t be so lucky.

If there is one PP the test is useless. However, the following two statements are true because of the above test: if the second PP is a complement, then the first PP must be a complement t, and if the ...

At the heart of the complement system are two large proteins, complement component C3 and protease factor B. These two proteins are pivotal for amplification of the complement response and for ...